RUNX1T1 and acute myeloid leukemia: A recent prospective study including patients treated with chemotherapy only has demonstrated that KIT mutations in exon 17 are prognostic factor in AML with RUNX1/RUNX1T1 after evaluating all types of KIT mutations [8].